The management of recurrent endobronchial lung cancer presents a significant challenge, necessitating a balance between oncological control and functional preservation of the lung. We report the case of a 74-year-old man presented with hemoptysis because of recurrent squamous cell carcinoma in the left main bronchus, successfully treated with bronchial sleeve resection despite significant comorbidities and antiplatelet therapy, highlighting its feasibility in complex scenarios. The patient had obstructive ventilatory impairment; the forced vital capacity (FVC) of 3.16 L, and forced expiratory volume in one second (FEV 1.0 ) of 1.72 L. We were able to remove the tumor while preserving lung function in patients with low lung function. Postoperatively, the patient showed marked symptomatic improvement, with no significant loss of pulmonary capacity or other complications. This case suggests that bronchial sleeve resection is a feasible and effective treatment option for patients with recurrent central airway squamous cell carcinoma, showing immediate symptomatic relief and improved quality of life. This approach enables the patient to endure forthcoming systemic therapies.
Watanabe et al. (Fri,) studied this question.